Trial Profile
An Open Label Study in Adults With Atopic Dermatitis to Assess Variability in Immune Response to Fluzone Intradermal Vaccine.
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 01 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Feb 2012 New trial record